Sopharma AD-Sofia (WAR:SPH) Inventories, Finished Goods: zł1,012 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SPH Sopharma AD-Sofia WAR:SPH
67 GF Score
Price zł7.50
GF Value zł13.42
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia Inventories, Finished Goods?

Sopharma AD-Sofia WAR:SPH +3.02% 67 Inventories, Finished Goods is zł1,012 Mil as of Mar. 2026. GuruFocus rates WAR:SPH with a GF Score™ of 67/100 and a GF Value™ of zł13.42 (Possible Value Trap). The stock has 4 warning signs investors should review.

Sopharma AD-Sofia's quarterly finished goods increased from Sep. 2025 (zł944 Mil) to Dec. 2025 (zł973 Mil) and increased from Dec. 2025 (zł973 Mil) to Mar. 2026 (zł1,012 Mil).

Sopharma AD-Sofia's annual finished goods increased from Dec. 2023 (zł561 Mil) to Dec. 2024 (zł765 Mil) and increased from Dec. 2024 (zł765 Mil) to Dec. 2025 (zł973 Mil).

Sopharma AD-Sofia Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Sopharma AD-Sofia's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia Inventories, Finished Goods Chart

Sopharma AD-Sofia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 448.74 449.07 560.53 765.15 973.33

Sopharma AD-Sofia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 830.03 878.15 943.69 973.33 1,012.32
WAR:SPH
67GF Score
Sopharma AD-Sofia WAR:SPH
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma AD-Sofia Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of zł1,012 Mil mean?
Sopharma AD-Sofia (WAR:SPH) has a Inventories, Finished Goods of zł1,012 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Sopharma AD-Sofia and its competitors.
Is Sopharma AD-Sofia's Inventories, Finished Goods too high?
Sopharma AD-Sofia's current Inventories, Finished Goods is zł1,012 Mil. Overall, Sopharma AD-Sofia has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's Inventories, Finished Goods compare to MCK and CAH?
Sopharma AD-Sofia's Inventories, Finished Goods of zł1,012 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Distribution company?
A good Inventories, Finished Goods depends on the Medical Distribution industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Sopharma AD-Sofia and its competitors. Sopharma AD-Sofia's current Inventories, Finished Goods is zł1,012 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (WAR:SPH) is currently considered Possible Value Trap. The stock's GF Value™ is zł13.42, compared to a current price of zł7.50 — trading 44.1% below its estimated fair value. The current Inventories, Finished Goods is zł1,012 Mil. Sopharma AD-Sofia's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Sopharma AD-Sofia (WAR:SPH), the current Inventories, Finished Goods is zł1,012 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma AD-Sofia (WAR:SPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued. The current stock price of zł7.50 is trading 44.1% below its estimated GF Value™ of zł13.42. GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.

Key valuation signals for WAR:SPH:

  • Inventories, Finished Goods: zł1,012 Mil
  • GF Value™: zł13.42 vs. price of zł7.50 (44.1% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the WAR:SPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sopharma AD-Sofia Business Description

Other Exchanges 3JR:GermanySFA:Bulgaria
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
67GF Score

Get the complete analysis for WAR:SPH

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł7.50
Price
zł13.42
GF Value